Conditional β-Catenin Loss in Mice Promotes Chemical Hepatocarcinogenesis: Role of Oxidative Stress and Platelet-Derived Growth Factor Receptor α/Phosphoinositide 3-Kinase Signaling†
Open Access
- 26 August 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 52 (3) , 954-965
Abstract
Activation of β-catenin, the central effector of the canonical Wnt pathway and a recognized oncogene, has been implicated in hepatocellular carcinoma. We examined N -nitrosodiethylamine (DEN)-induced tumorigenesis in hepatic β-catenin conditional knockout mice (β-cat KO). Male β-cat KO and age- and sex-matched littermate controls were given a single intraperitoneal DEN injection and followed for 6-12 months for hepatic tumors. Hepatic tumors were characterized for histology, proliferation, apoptosis, oxidative stress, and specific proteins by way of western blot, immunohistochemistry, and coprecipitation studies. For in vivo tumor intervention studies, specific inhibitors were administered intraperitoneally or through drinking water. Intriguingly, β-cat KO mice showed a paradoxical increase in susceptibility to DEN-induced tumorigenesis. This accelerated tumorigenesis is due to increased injury and inflammation, unrestricted oxidative stress, fibrosis, and compensatory increase in hepatocyte proliferation secondary to platelet-derived growth factor receptor α (PDGFRα)/phosphoinositide 3-kinase (PIK3CA)/Akt activation and c-Myc overexpression. In vitro suppression of β-catenin expression in hepatoma cells led to enhanced PDGFRα expression, which was abrogated in the presence of nuclear factor κB (NF-κB) inhibitor. Daily treatment of 6-month-old DEN-exposed β-cat KO with PDGFRα inhibitor dramatically reduced tumor numbers and size. Inclusion of N -acetyl-L-cysteine, a known antioxidant and NF-κB inhibitor, in the drinking water led to complete abolition of tumorigenesis in DEN-exposed β-cat KO. Conclusion: Loss of β-catenin impairs the liver's ability to counteract DEN-induced oxidative stress and enhances tumorigenesis through PDGFRα/PIK3CA/Akt signaling. Blockade of PDGFRα or oxidative stress dramatically affects β-catenin–deficient tumorigenesis. Also, hepatoma cells use PDGFRα/PIK3CA signaling as an escape mechanism following β-catenin suppression, and their sequential suppression profoundly impedes tumor proliferation.Keywords
This publication has 51 references indexed in Scilit:
- Role of Wnt/β-catenin signaling in liver metabolism and cancerThe International Journal of Biochemistry & Cell Biology, 2011
- Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteineJournal of Clinical Investigation, 2009
- PDGFRα: a new therapeutic target in the treatment of hepatocellular carcinoma?Expert Opinion on Therapeutic Targets, 2009
- Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary stepsCurrent Opinion in Oncology, 2008
- Loss of Hepatocyte Growth Factor/c-Met Signaling Pathway Accelerates Early Stages of N-nitrosodiethylamine–Induced HepatocarcinogenesisCancer Research, 2007
- Platelet-derived growth factor receptor-α: a novel therapeutic target in human hepatocellular cancerMolecular Cancer Therapeutics, 2007
- TGF-β1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cellsKidney International, 2006
- Hepatocellular carcinoma pathogenesis: from genes to environmentNature Reviews Cancer, 2006
- Liver‐specific loss of β‐catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice†‡Hepatology, 2006
- β-catenin interacts with and inhibits NF-κB in human colon and breast cancerCancer Cell, 2002